Morgan Stanley
HIMS icon

Morgan Stanley’s Hims & Hers Health HIMS Stock Holding History

Morgan Stanley’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248M Sell
7,152,498
-1,736,590
-20% -$46.6M 0.01% 890
2026
Q1 		$185M Buy
8,889,088
+4,959,856
+126% +$117M 0.01% 1003
2025
Q4 		$128M Sell
3,929,232
-3,346,864
-46% -$143M 0.01% 1242
2025
Q3 		$413M Buy
7,276,096
+1,747,072
+32% +$89.5M 0.03% 591
2025
Q2 		$276M Buy
5,529,024
+811,626
+17% +$36.7M 0.02% 716
2025
Q1 		$139M Buy
4,717,398
+688,407
+17% +$25.6M 0.01% 1043
2024
Q4 		$97.4M Buy
4,028,991
+1,907,118
+90% +$47.2M 0.01% 1265
2024
Q3 		$39.1M Sell
2,121,873
-588,184
-22% -$10.5M ﹤0.01% 2089
2024
Q2 		$54.7M Sell
2,710,057
-5,340
-0.2% -$88.9K ﹤0.01% 1683
2024
Q1 		$42M Buy
2,715,397
+1,493,059
+122% +$16.8M ﹤0.01% 1915
2023
Q4 		$10.9M Sell
1,222,338
-255,143
-17% -$1.89M ﹤0.01% 3257
2023
Q3 		$9.29M Sell
1,477,481
-1,179,456
-44% -$8.77M ﹤0.01% 3189
2023
Q2 		$25M Buy
2,656,937
+384,809
+17% +$3.82M ﹤0.01% 2245
2023
Q1 		$22.5M Buy
2,272,128
+1,146,886
+102% +$10.1M ﹤0.01% 2294
2022
Q4 		$7.21M Buy
1,125,242
+915,928
+438% +$5.21M ﹤0.01% 3399
2022
Q3 		$1.17M Sell
209,314
-4,534
-2% -$27.3K ﹤0.01% 4793
2022
Q2 		$970K Sell
213,848
-523,320
-71% -$2.23M ﹤0.01% 5034
2022
Q1 		$3.93M Buy
737,168
+295,579
+67% +$1.46M ﹤0.01% 3939
2021
Q4 		$2.89M Sell
441,589
-604,575
-58% -$4.37M ﹤0.01% 4272
2021
Q3 		$7.89M Buy
1,046,164
+971,920
+1,309% +$8.23M ﹤0.01% 3182
2021
Q2 		$808K Buy
74,244
+61,774
+495% +$734K ﹤0.01% 5208
2021
Q1 		$165K Sell
12,470
-25,174
-67% -$422K ﹤0.01% 5767
2020
Q4 		$550K Buy
37,644
+30,213
+407% +$335K ﹤0.01% 5023
2020
Q3 		$87K Buy
+7,431
New +$79.2K ﹤0.01% 5494

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Morgan Stanley's HIMS Position: Q2 2026 in Review

Morgan Stanley reduced its Hims & Hers Health (HIMS) stake by 20% in Q2 2026, selling an estimated $46.6M and leaving 7,152,498 shares worth $248M. The position accounts for 0.01% of the portfolio, ranked #890.

Morgan Stanley first reported a position in HIMS in Q3 2020 and has held it in 24 quarters since. The position peaked at $413M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Morgan Stanley held 7,152,498 shares of Hims & Hers Health worth $248M as of Q2 2026.
  • Morgan Stanley sold 1,736,590 Hims & Hers Health shares in Q2 2026, an estimated $46.6M.
  • Hims & Hers Health made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #890 holding.
  • Morgan Stanley first reported a position in Hims & Hers Health in Q3 2020 and has held it in 24 quarters since.
  • Morgan Stanley's Hims & Hers Health position peaked at $413M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.